463 related articles for article (PubMed ID: 31529626)
1. Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review.
Lafuente Ibáñez de Mendoza I; Maritxalar Mendia X; García de la Fuente AM; Quindós Andrés G; Aguirre Urizar JM
J Periodontal Res; 2020 Jan; 55(1):13-22. PubMed ID: 31529626
[TBL] [Abstract][Full Text] [Related]
2. Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties.
Ha NH; Woo BH; Kim DJ; Ha ES; Choi JI; Kim SJ; Park BS; Lee JH; Park HR
Tumour Biol; 2015 Dec; 36(12):9947-60. PubMed ID: 26178482
[TBL] [Abstract][Full Text] [Related]
3. Human Primary Epithelial Cells Acquire an Epithelial-Mesenchymal-Transition Phenotype during Long-Term Infection by the Oral Opportunistic Pathogen,
Lee J; Roberts JS; Atanasova KR; Chowdhury N; Han K; Yilmaz Ö
Front Cell Infect Microbiol; 2017; 7():493. PubMed ID: 29250491
[No Abstract] [Full Text] [Related]
4. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model.
Binder Gallimidi A; Fischman S; Revach B; Bulvik R; Maliutina A; Rubinstein AM; Nussbaum G; Elkin M
Oncotarget; 2015 Sep; 6(26):22613-23. PubMed ID: 26158901
[TBL] [Abstract][Full Text] [Related]
5.
Chang C; Wang H; Liu J; Pan C; Zhang D; Li X; Pan Y
ACS Infect Dis; 2019 Aug; 5(8):1336-1347. PubMed ID: 31243990
[TBL] [Abstract][Full Text] [Related]
6. The prevalence rate of periodontal pathogens and its association with oral squamous cell carcinoma.
Chang C; Geng F; Shi X; Li Y; Zhang X; Zhao X; Pan Y
Appl Microbiol Biotechnol; 2019 Feb; 103(3):1393-1404. PubMed ID: 30470868
[TBL] [Abstract][Full Text] [Related]
7. Porphyromonas gingivalis promotes the progression of oral squamous cell carcinoma by activating the neutrophil chemotaxis in the tumour microenvironment.
Guo ZC; Jing SL; Jumatai S; Gong ZC
Cancer Immunol Immunother; 2023 Jun; 72(6):1523-1539. PubMed ID: 36513851
[TBL] [Abstract][Full Text] [Related]
8. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation.
Inaba H; Sugita H; Kuboniwa M; Iwai S; Hamada M; Noda T; Morisaki I; Lamont RJ; Amano A
Cell Microbiol; 2014 Jan; 16(1):131-45. PubMed ID: 23991831
[TBL] [Abstract][Full Text] [Related]
9. About a Possible Impact of Endodontic Infections by
Ciani L; Libonati A; Dri M; Pomella S; Campanella V; Barillari G
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791123
[TBL] [Abstract][Full Text] [Related]
10. Porphyromonas gingivalis in oral squamous cell carcinoma: a review.
Singh S; Singh AK
Microbes Infect; 2022; 24(3):104925. PubMed ID: 34883247
[TBL] [Abstract][Full Text] [Related]
11. Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells.
Sztukowska MN; Ojo A; Ahmed S; Carenbauer AL; Wang Q; Shumway B; Jenkinson HF; Wang H; Darling DS; Lamont RJ
Cell Microbiol; 2016 Jun; 18(6):844-58. PubMed ID: 26639759
[TBL] [Abstract][Full Text] [Related]
12. sRNA23392 packaged by Porphyromonas gingivalis outer membrane vesicles promotes oral squamous cell carcinomas migration and invasion by targeting desmocollin-2.
Liu D; Liu S; Liu J; Miao L; Zhang S; Pan Y
Mol Oral Microbiol; 2021 Jun; 36(3):182-191. PubMed ID: 33764008
[TBL] [Abstract][Full Text] [Related]
13. Serum Levels of Interleukin-6 and Titers of Antibodies Against
Park DG; Woo BH; Lee BJ; Yoon S; Cho Y; Kim YD; Park HR; Song JM
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167516
[TBL] [Abstract][Full Text] [Related]
14. [Research progress on the relationship between Porphyromonas gingivalis and oral squamous cell carcinoma].
Wu-chao W; Yafei W; Lei Z
Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Dec; 33(6):651-5. PubMed ID: 27051963
[TBL] [Abstract][Full Text] [Related]
15. Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs.
Ha NH; Park DG; Woo BH; Kim DJ; Choi JI; Park BS; Kim YD; Lee JH; Park HR
Cytokine; 2016 Oct; 86():64-72. PubMed ID: 27468958
[TBL] [Abstract][Full Text] [Related]
16. Persistent Exposure to
Geng F; Liu J; Guo Y; Li C; Wang H; Wang H; Zhao H; Pan Y
Front Cell Infect Microbiol; 2017; 7():57. PubMed ID: 28286742
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of Porphyromonas gingivalis-derived phosphoethanolamine dihydroceramide on acid ceramidase expression in oral squamous cells.
Yamada C; Ho A; Nusbaum A; Xu R; Davey ME; Nichols F; Mao C; Movila A
J Cell Mol Med; 2023 May; 27(9):1290-1295. PubMed ID: 37016912
[TBL] [Abstract][Full Text] [Related]
18.
Liu S; Zhou X; Peng X; Li M; Ren B; Cheng G; Cheng L
J Immunol; 2020 Jul; 205(1):282-289. PubMed ID: 32471882
[TBL] [Abstract][Full Text] [Related]
19.
Groeger S; Herrmann JM; Chakraborty T; Domann E; Ruf S; Meyle J
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408801
[TBL] [Abstract][Full Text] [Related]
20. Role of oral microbiome in oral oncogenesis, tumor progression, and metastasis.
Li R; Xiao L; Gong T; Liu J; Li Y; Zhou X; Li Y; Zheng X
Mol Oral Microbiol; 2023 Feb; 38(1):9-22. PubMed ID: 36420924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
